Skip to content

INTEGRATED BIOPHARMA INC

INBP

CIK 0001016504

← back to feed
Revenue (TTM)
$41.3M
−6.9% YoY Q3 May 2026
Net Income (TTM)
−$865K
+621.4% YoY Q3 May 2026
EPS Diluted (TTM)
−$0.04
Q3 May 2026
Gross Margin
5.6%
Q3 May 2026
Operating Margin
-2.7%
Q3 May 2026
Net Margin
-2.1%
Q3 May 2026
Free Cash Flow (TTM)
$3.95M
Q3 May 2026
Cash
$5.83M
Q3 May 2026
Total Debt
$18K
Q3 May 2026
Shares Outstanding
31.06M sh
Q3 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings